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Obesity has become a major public health burden
worldwide due to the huge social and economic impact
derived from its related comorbidities [1]. Excessive
body weight has been estimated to account for 16 % of
the global burden disease [2] and according to World
Health Organization estimates, over 600 million adults
are obese worldwide Obesity is described as a multi-
etiological disorder and several factors have been
shown to be involved in its onset and development [1].
Despite the important progression in the study of obes-
ity, prevalence rates continue to increase, suggesting
that additional elements must be involved in the patho-
genesis of this disease. Moreover, even if weight loss
programs are effective, keeping the weight off continues
to be an almost insurmountable challenge [3]. In this
context, new theories are arising regarding food intake.
Understanding obesity as a food addiction is a novel ap-
proach that has garnered considerable attention. Some
studies have shown an association between mood and
the overall dietary pattern including specific nutrients
[4]. Recent research also shows that palatable and high
calorie food may have addictive potential. Subjects
chronically eat some foods in amounts larger than
needed for staying healthy, which shows a loss of con-
trol in food behaviour [5]. Additionally, a 40 % preva-
lence of food addiction has been shown in obese
individuals seeking bariatric surgery [6]. All these traces
indicate that there may be a potential relationship be-
tween behaviour and weight gain.* Correspondence: patricia.lopez@uautonoma.cl
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In recent years, there has been an increase in scientific
evidence showing both neurobiological and behavioral
relationships between drugs and food intake. Basic re-
search using animal and humans models has shown that
certain foods, mainly highly palatable foods, have addict-
ive properties. In addition, exposure to food and drugs
of abuse have shown similar responses in the dopamin-
ergic and opioid systems. These similarities between
food and drugs have given rise to the hypothesis of food
addiction.Food intake and brain reward circuits
The dopaminergic system is involved in a large number
of behaviors including reward processing and motivated
behavior. Thus, all drugs of abuse increase the extracel-
lular concentration of dopamine (DA) in the striatum
and associated mesolimbic regions [7]. Di Chiara’s group
has extensively showed that addictive drugs (e.g. am-
phetamine and cocaine) increase extracellular DA in the
nucleus accumbens (NAc), a primary site for reinforced
behaviors [7]. Likewise, microdialysis has shown that ex-
posure to rewarding food stimulates dopaminergic trans-
mission in the NAc [8].
Furthermore, neuroimaging studies show that our
brain response is similar in the presence of food and
drug abuse: increased cell activation in the NAc, the
brain’s pleasure center [9–11]. Neuroimaging studies in
humans have also shown similarities between obesity
and addiction. For example, both obesity and addiction
are associated with fewer D2 dopamine receptors in the
brain [12, 13], suggesting that they are less sensitive to
reward stimuli and more vulnerable to food or drug in-
take. Thus, for example, individuals with the largest
body mass index (BMI) had the lowest D2 values [13].is article is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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lates with reduced metabolism in cerebral areas (pre-
frontal and orbitofrontal cortex) that exert inhibitory
control over consumption [12]. Thus, obese subjects
show greater activation of reward and attention regions
than normal weight subjects do in response to palatable
food images versus control images [14, 15]. This obser-
vation suggests that a deficit in reward processing is an
important risk factor for the impulsive and compulsive
behaviors showed by obese individuals. Taken together,
these data could explain why in obesity and drug addic-
tion the consummatory behaviors persist despite nega-
tive social, health and financial consequences. All these
neurobiological data suggest that obesity and drug addic-
tion may share similar neuroadaptive responses in brain
reward circuits or action mechanisms.
The role of nutrition neuropeptides in addiction
The idea that neuropeptides involved in metabolic regu-
lation are also involved in modulating the neurobio-
logical responses to drugs of abuse has received a great
deal of attention in recent literature [16, 17]. Several
studies have shown that exposure to drugs of abuse sig-
nificantly alters the functionality of numerous neuropep-
tides systems. On the other hand, compounds that target
these neuropeptides systems play an important role in
modulating the neurobiological responses to drugs of
abuse. For example, the melanocortins (MC) and orexins
system, which plays an important role in food intake, is
also involved in drug use. Moreover, the brain expression
of these neuropeptides is altered after drug binge-like con-
sumption [18–20] or palatable substances (caloric and
non-caloric) [21]. Central administration of Agouti-related
peptide, an MC antagonist, activates midbrain dopamine
neurons and induces consumption of fat enriched foods
[22]. Taken together, this data could explain why some
kinds of food are so often overconsumed.
Regulatory mechanisms for food intake can be
homeostatic –biological need– but also hedonic [23].
This idea is supported by the fact that people continue
eating even when energy requirements have been met.
However, it is noteworthy that these systems (hedonic
versus homeostatic) are not mutually exclusive, but will
have multiple interconnections [24]. Homeostatic regu-
lators of hunger and satiety, such as ghrelin, leptin and
insulin, could mediate between the homeostatic and he-
donic mechanisms of food intake influencing the dopa-
minergic system [25, 26]. Leptin is perhaps the most
widely studied biological factor in relation to food intake
control. Although it is secreted by the adipose tissue, lep-
tin receptors are expressed on midbrain dopamine neu-
rons [27]. Leptin infusion into the tegmental ventral area,
a reward system brain area, decreases food intake and in-
hibits the activity of dopamine neurons [28]. Thus, currentevidence suggests that mesolimbic dopamine pathways
could mediate the effect of leptin on food intake.
Therefore, theories of “food addiction” indicate that
certain highly processed foods can have a high addictive
potential and may be responsible for some cases of obes-
ity and eating disorders [29, 30]. Recently, it have been
shown that subjects showing a compulsive overeating
consume higher amounts of some macronutrients (fats
and proteins) compared with non-food-addicted subjects
[31, 32]. It is well established that hyperphagia induced
by consumption of fat enriched food and refined sugars
is influenced by mesolimbic and nigrostriatal dopamin-
ergic inputs. For example, consumption of highly palatable
food, especially sugar, entails the release of endogenous
opioids in the NAc [33, 34] and activates the dopamin-
ergic reward system [35]. In addition, the rats exposed to
intermittent access to sugar solution show some compo-
nents of addiction such as escalation of daily sugar intakes,
withdrawal signs, craving and cross-sensitization to am-
phetamine and alcohol [36]. These data suggest that
certain foods are potentially rewarding and can trigger
addictive-like behaviors in laboratory animals and
humans.
How to evaluate food addiction
As mentioned before, obesity is a heterogeneous disease
influenced by multiple factors. This review has shown
how an addictive process may play a role in binge eating
and obesity. Thus, food addiction could be a factor con-
tributing to overeating and then to obesity. However, for
the scientific community the concept of food addiction is
still a controversial topic [5, 37, 38]. One of the arguments
to question the validity of food addiction hypothesis is that
although neurobiological studies have identified shared
brain mechanisms of food and drugs, there are substantial
differences too [37]. Also, the pattern of brain activation
of obese individuals and binge-eaters compared with con-
trols is inconsistent [38]. Finally, other critical remarks
argue that most of the studies that support the existence
of food addiction are restricted to animal models [5]. Bear-
ing in mind this criticism, future research is required to
more extensively study the validity of food addiction in
humans. Therefore, to evaluate this hypothesis of “food
addiction” and its contribution to eating disorders it be-
comes necessary to have valid and reliable instruments to
operationalize food addictive behaviors.
A tool to identify individuals showing symptoms of “de-
pendence” to certain foods has been recently developed.
Gearhardt and cols. elaborated in 2009 the Yale Food
Addiction Scale (YFAS) [39]. This scale has been used in
most of the research related to the concept of food addic-
tion and has been translated into several languages, such
as, French, German, Italian, Spanish or Dutch. The instru-
ment is a 25-item questionnaire grouped under criteria
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outlined in the Diagnostic and Statistical Manual of Men-
tal Disorders IV. The scale includes items that assess spe-
cific criteria, such as loss of control over consumption, a
persistent desire or repeated unsuccessful attempts to
quit, continued use despite physical and psychological
problems, and clinically significant impairment or distress,
among others. The most common symptoms of food ad-
diction are loss of control over consumption, continued
use despite negative consequences, and inability to cut
down despite the desire to do so [40].
Studies using the YFAS have found that patients scoring
high in the scale show more frequently binge eating epi-
sodes [22, 41, 42]. In turn, prevalence of food addiction di-
agnosed using YFAS was 5.4 % in general population [31].
However, food addiction increased with obesity status
range between 40 % and 70 % in individuals with binge eat-
ing disorder [42], compulsive-overeating [43] or bulimia
nervosa [6]. Furthermore, individuals with high food addic-
tion scores were found to have comparable responses when
viewing food images as individuals with drug dependence
viewing drug cues. They showed elevated activation in re-
ward circuitry (anterior cingulate cortex, dorsolateral pre-
frontal cortex and amygdala) in response to food cues and
reduced activation in inhibitory regions (medial orbitofron-
tal cortex) in response to food intake [29].
Interestingly, the prevalence of food addiction was
positively related to measures of adiposity (e.g. body fat,
BMI) [31, 44]. These data suggest that food addiction is
likely an important factor in the development of human
obesity and that it is associated with the severity of obesity
from normal to obese individuals. In fact, obese people
showing a worse weight loss response to treatment [41]
and greater weight gain after undergoing bariatric surgery
[45] obtain higher YFAS scores. Thus, weight-loss treat-
ments should consider the role of food addiction as a psy-
chological factor underlying difficult weight management
situations.
On the other hand, some personality traits, such as
impulsivity, have been associated with alcohol and drug
misuse [46]. In the context of food addiction, recent re-
search has demonstrated that obese individuals scoring
high in YFAS were more impulsive and displayed greater
emotional reactivity than obese controls [22]. These
findings suggest that a food addiction construct shows a
psycho-behavioral profile similar to conventional drug
abuse disorders.
However, although food addiction constructs exists, it
is highly unlikely that all foods have addictive potential.
Manufacturing industries have designed processed foods
by adding sugar, salt, or fat, which can maximize the re-
inforcing properties of traditional foods (fruits, vegeta-
bles). The high palatability (hedonic value) that this kind
of processed food offers, prompts subjects to eat more.Thus, certain processed food may have a high addictive
potential and be responsible for some eating disorders
such as obesity [30, 40]. Although there is little evidence
in humans, animal models suggest that processed food is
associated with addictive-like eating. For example, Avena
and cols. showed that excessive intake of sugar causes
neurochemical (increased release of dopamine and acetyl-
choline in NAc) and behavioral (increased intake of sugar
after a period of abstinence and cross-sensitivity to drugs
of abuse) signs of dependence [47]. These findings suggest
that overconsumption of highly processed food, but not
standard rat chow, produce some addictive-like character-
istics. Also, it has been shown that overconsumption of
palatable food triggers down-regulation of striatal D2 re-
ceptors expression in the same way that drugs do [48],
which suggests that obesity and drug addiction may share
an underlying hedonic mechanism, as noted above.
Nevertheless, not everyone exposed to palatable food
environments develops obesity. Knowing the biological
and/or behavioral motives or reasons why people eat
highly palatable foods could help explain the susceptibil-
ity or resilience with respect to obesity. Thus, by identi-
fying why people begin to eat these kinds of food it
could be possible to design appropriate “personalized”
treatments to combat obesity. The Palatable Motives
Eating Scale (PEMS) is a validated and robust scale to
identify motivations for eating highly-palatable foods
[49]. The scale allows detecting motives for eating tasty
food: social (e.g., to celebrate a special occasion with
friends), coping (e.g., to forget about your problems), re-
ward enhancement (e.g., because it gives you a pleasant
feeling) and conformity (e.g., because your friends or
family want you to eat or drink these foods or drinks).
Moreover, PEMS have a good convergent validity with
YFAS scores. It makes it possible to evaluate different
food addiction constructs. While the YFAS probes the
consequences of consuming highly palatable foods, the
PEMS probes the motives for such consumption.
Two examples of scales (YFAS and PEMS) to evaluate
food addiction have been shown.
Conclusion
As indicated above, obesity has become a major public
health problem worldwide. Therefore, finding efficient
strategies to fight this disease represents a big challenge
for the international scientific community. Studying the
possible role of food addiction in humans as an influen-
cing factor in excessive food intake is attracting attention.
More so, considering the interesting results obtained with
animals. It is known that some cases of excessive food in-
take do not respond to physiological needs but to a psy-
chological behavioural component that needs to be
identified. Finding this component would allow the inclu-
sion of behavioural therapy among the cornerstones of
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proach in accordance to the multifactorial origin of the
obesity. This more realistic grasp may allow applying ef-
fective treatments, leading not only to greater weight
loses, but also to a better chance of keeping the lost
weight off. YFAS and PEMS tools offer a rigorous way to
evaluate whether an addictive process contributes to cer-
tain eating disorders, such as obesity and binge eating.
However, further research is needed in order to evaluate
the food addiction hypothesis and its relationship to eating
disorders. It is necessary to study the effect of psycho-
logical, behavioral, cognitive and physiological factors in
the food addiction construct. In any case, certain foods
(fatty, sugary and salty) have shown to have an addictive
potential, thus implying the possibility of preventing and
treating obesity.
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